ABCC9 and diabetes mellitus: Given that SUR1 and SUR2 subunits are well-established drug targets in diabetes and cardiovascular diseases, the high expression of KATP channel subunits in the colon suggests their potential for pharmacological modulation of intestinal motility and barrier function.